#AIMDW

1 week ago

Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026 Ainos (NASDAQ:AIMD) announced continued validation of its AI Nose platform in front-end wafer fabs with ~200 targeted deployments planned in Q1 2026 for technical validation.It is executing Phase 1 of a 1,400-system back-end deployment worth approximately $2.1 million under a three-year subscription, targeting completion in Q2 2026. The broader roadmap contemplates up to 20,000 systems, which the company says could approach $10 million in annual subscription value, all subject to technical validation and contractual conversion. Management says milestones and subscription activation plans remain unchanged despite market volatility.

#AIMD #AIMDW Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026

www.stocktitan.net/news/AIMD/ainos-expands-...

0 0 0 0

StockTitan

@stocktitan.net

2 weeks ago

Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity Ainos (NASDAQ:AIMD) outlined a phased deployment plan for up to 20,000 AI Nose systems, anchored by a confirmed initial order of 1,400 systems.The initial order activates recurring subscription revenue under a three-year service structure totaling approximately $2.1 million, and the roadmap states potential annual order values approaching $10 million if fully executed, subject to staged technical validation and formal contractual conversion.Validation testing is underway in advanced semiconductor front-end fabrication environments to support commercial integration and multi-site industrial scaling.

#AIMD #AIMDW Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity

www.stocktitan.net/news/AIMD/ainos-issues-s...

0 0 0 0

StockTitan

@stocktitan.net

2 months ago

Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language Ainos (NASDAQ:AIMD) outlined a long-term platform strategy to digitize smell as a native AI data language and described a dual-engine SmellTech architecture split between hardware sensing and AI intelligence.Ainos will own design, manufacturing, deployment, and data generation for its AI Nose sensors while wholly owned ScentAI will develop the Smell Language Model (SLM) to classify, contextualize, and scale scent data via APIs, SaaS, and model licensing. 2026 priorities target scaled deployments in advanced semiconductor manufacturing and robotics to accelerate data accumulation and SLM training.

#AIMD #AIMDW Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language

www.stocktitan.net/news/AIMD/ainos-articula...

0 0 0 0

StockTitan

@stocktitan.net

3 months ago

Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc. Ainos (NASDAQ:AIMD / AIMDW) will relocate its U.S. headquarters to Houston, Texas in early 2026 and has formed a wholly owned software subsidiary, ScentAI Inc.ScentAI will develop a smell language model (SLM) that converts scent signals into Smell ID tokens and will be co-located with Ainos' HQ to integrate AI Nose hardware data with model development. Management described the move as improving operating efficiency and enabling U.S. commercialization after recent deployments in Asia.

#AIMD #AIMDW Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc.

www.stocktitan.net/news/AIMD/ainos-to-reloc...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Ainos Reports Third Quarter 2025 Financial Results Ainos (NASDAQ:AIMD) reported third-quarter 2025 developments as it accelerates commercial scale-up of its AI Nose scent‑digitization platform ahead of 2026. Key operational moves include expanding industrial partnerships to six, a distribution agreement with Topco across the U.S., Taiwan, Japan and Southeast Asia, a strategic partnership with NEXCOM (Oct 14, 2025), and reclassification under GICS to Technology Hardware, Storage & Peripherals effective Oct 1, 2025. The company launched its first commercial portable AI Nose (Aug 14, 2025) and added seven patents on Sep 30, 2025, bringing the total to 123 active patents. Management cited cost discipline with S,G&A down 22% YoY and total operating expenses down 8%.

#AIMD #AIMDW Ainos Reports Third Quarter 2025 Financial Results

www.stocktitan.net/news/AIMD/ainos-reports-...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

Water Tower Research Spotlights Ainos-NEXCOM Partnership as Catalyst for High-Growth Edge AI Expansion Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM to integrate its AI Nose scent‑based edge AI solution into NEXCOM's industrial edge computing and automation platforms. The collaboration is Ainos' sixth industrial partnership in 2025 and aims to enable real‑time environmental sensing, predictive maintenance, and improved sustainability by processing olfactory data at the edge instead of the cloud. The deal leverages NEXCOM's network of 117 partners across 50 countries and aligns with an edge AI market projected at $57–$66 billion by 2030. Ainos targets a commercial launch in 2026 for AI Nose and cites enhanced industrial channels via NEXCOM's global footprint.

#AIMD #AIMDW Water Tower Research Spotlights Ainos-NEXCOM Partnership as Catalyst for High-Growth Edge AI Expansion

www.stocktitan.net/news/AIMD/water-tower-re...

0 0 0 0

StockTitan

@stocktitan.net

5 months ago

Ainos and NEXCOM Partner to Expand AI Nose Ecosystem into Industrial Edge AI Ainos (NASDAQ:AIMD) announced a strategic partnership with NEXCOM on October 14, 2025 to integrate Ainos' AI Nose hardware, SmellTech, and Smell Language Model into NEXCOM's industrial edge AI and automation platforms.The collaboration targets real-time environmental sensing for manufacturing and industrial applications, enabling intelligent monitoring, predictive maintenance, and sustainable operations while leveraging NEXCOM's global edge computing footprint and channels.

#AIMD #AIMDW Ainos and NEXCOM Partner to Expand AI Nose Ecosystem into Industrial Edge AI

www.stocktitan.net/news/AIMD/ainos-and-nexc...

0 0 0 0

StockTitan

@stocktitan.net

5 months ago

Water Tower Research Highlights Ainos' Transition to Technology Company Following GICS Reclassification Ainos (NASDAQ:AIMD) was reclassified under GICS from biotechnology to the technology sector effective October 1, 2025, reflecting its shift to an AI-powered digital olfaction platform, AI Nose.Water Tower Research highlighted commercial milestones: first revenue of $110,000 from a 1H 2025 elderly care pilot, a three-year SmellTech-as-a-Service order worth $2.1 million for semiconductor manufacturing, seven Japan pilots with a robotic partner, five new industry partners, and an expanded IP portfolio now at 123 active patents and applications including seven recent patents across Europe, Germany, Taiwan, and China. Large-scale commercialization is scheduled for 2026.

#AIMD #AIMDW Water Tower Research Highlights Ainos' Transition to Technology Company Following GICS Reclassification

www.stocktitan.net/news/AIMD/water-tower-re...

0 0 0 0

StockTitan

@stocktitan.net

5 months ago

AI Smell Tech Drives 435% Revenue Growth: Ainos Lands $2.1M Deal and Major Tech Partnerships AI scent digitization firm Ainos reclassifies to GICS tech sector, reports 435% H1 revenue growth, and secures $2.1M SmellTech SaaS contract. Partners with 5 industry leaders in semiconductors and robotics.

#AIMD #AIMDW Ainos Announces GICS Reclassification to Information Technology Sector

www.stocktitan.net/news/AIMD/ainos-announce...

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

AI-Powered Digital Smell Technology: Ainos Teams with Semiconductor Giant Topco for Global Rollout Ainos (NASDAQ:AIMD) partners with Topco Scientific for distribution of AI Nose platform across Taiwan, Japan, SE Asia, and US. Deal spans semiconductor, healthcare, and smart manufacturing sectors.

#AIMD #AIMDW Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose

www.stocktitan.net/news/AIMD/ainos-and-topc...

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up Ainos (NASDAQ:AIMD) is transforming from a biotech company into a pioneering SmellTech leader through its AI Nose platform. The Water Tower Research report highlights the company's strategic pivot following its 2021 acquisition of AI Nose, which enables artificial intelligence to detect and process scents.The company has secured strategic partnerships with major industry players including ASE Technology Holding, ugo, Inc., Kenmec Mechanical Engineering, and Solomon Technology. A significant milestone includes a $2.1 million contract for 1,400 AI Nose units in the semiconductor sector, with potential expansion to 15,000 units.Ainos plans to scale its AI Nose deployment in 2026, implementing a SmellTech-as-a-Service (SaaS) model across healthcare, robotics, semiconductors, and smart manufacturing sectors. The company's competitive advantage stems from its proprietary smell language model (SLM) and extensive Smell ID data collection.

#AIMD #AIMDW Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up

www.stocktitan.net/news/AIMD/water-tower-re...

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

$2.1M AI Smell Detection Deal: Ainos's AI Nose Platform Breaks Into Semiconductor Industry with Major Contract AI-powered scent detection company Ainos secures 3-year SmellTech contract with leading semiconductor firm. Platform expands beyond healthcare into robotics and manufacturing. First revenues of $110K in 1H25.

#AIMD #AIMDW Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation

www.stocktitan.net/news/AIMD/water-tower-re...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

Revolutionary AI Nose Device Brings Digital Smell Detection to Semiconductor and Healthcare Industries Patented AI olfaction platform enables machines to detect scents with human-like precision. Subscription-based system targets semiconductor, manufacturing, and healthcare sectors. Learn more.

#AIMD #AIMDW Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare

www.stocktitan.net/news/AIMD/ainos-debuts-w...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

Ainos Reports Second Quarter 2025 Financial Results Ainos (NASDAQ:AIMD) reported Q2 2025 financial results highlighting significant commercial progress for its AI Nose scent digitization platform. The company secured its first three-year subscription order worth $2.1 million for semiconductor manufacturing applications and generated initial revenue from the senior care sector.AI Nose demonstrated strong performance metrics, achieving 85% accuracy in eldercare hygiene detection, 80% in semiconductor facilities, and 90% in food/beverage scent classification. The company unveiled a 90-day roadmap targeting approximately 1,400 pilot deployments, with plans to expand to 5,000 units in Phase 1 and potentially 15,000 units in Phase 2.Ainos established strategic partnerships with key players including ASE Technology, Solomon, and Kenmec to accelerate AI Nose adoption across robotics, semiconductors, and smart manufacturing. The company also completed a 1-for-5 reverse stock split to regain Nasdaq compliance.

#AIMD #AIMDW Ainos Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/AIMD/ainos-reports-...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

First Side-Effect-Free Treatment for 3.1M Sjögren's Syndrome Patients Advances with TFDA Trial Approval Novel oral interferon-alpha drug shows promise for Sjögren's syndrome after successful 497-patient US trials. Zero serious adverse events reported. Learn more.

#AIMD #AIMDW Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome

www.stocktitan.net/news/AIMD/ainos-receives...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector Ainos (NASDAQ:AIMD) has announced a groundbreaking partnership with ugo Inc. to launch the world's first AI Nose-enabled service robots across seven pilot sites in Japan. The robots will be deployed in pharmaceutical manufacturing, facility management, energy operations, power substations, and water treatment plants.The AI Nose technology has demonstrated impressive accuracy rates: 80% accuracy across 22 industrial scent types in semiconductor facilities, 85% accuracy in senior care pilots, and over 90% accuracy in food and beverage testing. The company plans to deploy approximately 1,400 AI Nose units with ASE and expand to 5,000 units in Phase 1.This initiative is part of Ainos' 90-day action plan and positions the company for a global SmellTech-as-a-Service rollout in 2026. The global electronic nose market is projected to grow from $29.79 billion in 2025 to $76.45 billion by 2032.

#AIMD #AIMDW Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector

www.stocktitan.net/news/AIMD/ainos-and-ugo-...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026 Ainos (NASDAQ:AIMD) has regained Nasdaq compliance and unveiled its 90-day roadmap for scaling its AI Nose platform. The company reported significant achievements, including a 412% year-over-year revenue increase in Q1 2025 and strategic partnerships with major industry players like ASE Technology Holding for deploying up to 15,000 AI Nose units.The company's proprietary smell language model (SLM) has achieved 90% accuracy in classifying everyday scents, while its senior care program improved to 85% accuracy. Key partnerships with Kenmec and Solomon aim to integrate AI-powered scent intelligence into smart factory systems. The company also completed the first-ever integration of AI Nose with a humanoid robot through ugo Inc.Ainos's 90-day plan focuses on deploying 1,400 AI Nose units with ASEH, expanding to 5,000 units, and launching SmellTech-as-a-Service (SaaS) as a subscription-based revenue model.

#AIMD #AIMDW Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026

www.stocktitan.net/news/AIMD/ainos-regains-...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape Ainos (NASDAQ:AIMD) has announced a strategic five-year distribution partnership with Solomon Technology Corporation to expand its AI Nose platform across Asia's industrial sectors. The partnership combines Ainos' smell language model (SLM) with Solomon's Visual Language Model (VLM) to create an advanced sensory intelligence platform.The collaboration targets key manufacturing sectors including semiconductors, petrochemicals, autonomous mobile robots (AMRs), and healthcare. This expansion builds on Ainos' existing partnerships with ASE, Kenmec, and ugo. The global electronic nose market is projected to grow from $29.8B in 2025 to $76.5B by 2032, with Asia controlling over 70% of global semiconductor capacity and 45% of electronics manufacturing services.

#AIMD #AIMDW Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape

www.stocktitan.net/news/AIMD/ainos-and-solo...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization Ainos (NASDAQ:AIMD) has completed a 1-for-5 stock consolidation effective June 30, 2025, while announcing significant progress in its AI-powered olfactory intelligence business. The company is targeting the electronic nose market, projected to grow from $29.8 billion in 2025 to $76.5 billion by 2032. The company has established key partnerships for AI Nose deployment: ASE Technology Holding (planning deployment of 1,400 units in pilot phase, scaling to 5,000 in Phase 1 and 15,000 in Phase 2), Kenmec Mechanical Engineering for smart factory integration, and ugo for robotics applications in Japan. In Q1 2025, Ainos reported a 412% year-over-year revenue growth. The company's Smell Language Model (SLM) has achieved over 90% accuracy in classifying meat, food, and beverage samples. In the senior care sector, their technology demonstrated 85%+ accuracy in hygiene detection across 2,000+ samples. Additionally, Ainos is advancing clinical trials for VELDONA® in Taiwan for HIV-related oral warts and Sjögren's syndrome.

#AIMD #AIMDW Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization

www.stocktitan.net/news/AIMD/ainos-complete...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Revolutionary AI Scent Technology: 15,000 AI Nose Units to Transform Semiconductor Manufacturing First-ever large-scale AI scent monitoring system in semiconductor industry. Multi-million revenue potential from 15,000-unit deployment. Learn deployment timeline.

#AIMD #AIMDW Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites

www.stocktitan.net/news/AIMD/ainos-and-ase-...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation Ainos (NASDAQ:AIMD) announced a 1-for-5 stock consolidation effective June 30, 2025, aimed at attracting institutional investors and maintaining Nasdaq listing compliance. The consolidation will automatically convert every 5 shares into 1 share, with fractional shares paid in cash.The company is entering a commercial execution phase in 2H 2025, focusing on two main verticals: AI Nose, an AI-powered scent digitization platform entering scaled field testing across senior care, robotics, and semiconductor manufacturing, and VELDONA®, a low-dose oral interferon in clinical development for both human and veterinary applications including feline chronic gingivostomatitis, Sjögren's syndrome, and HIV-related oral warts.

#AIMD #AIMDW Ainos Aligns Capital Structure With 2H 2025 Execution Roadmap; Announces Stock Consolidation

www.stocktitan.net/news/AIMD/ainos-aligns-c...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia Ainos (NASDAQ:AIMD) has formed a strategic partnership with Kenmec Mechanical Engineering to integrate AI-powered scent intelligence into smart factories across Asia. The partnership enables Kenmec to deploy AI Nose and smell language model (SLM) technologies in automation solutions, with Kentec Inc. appointed as a manufacturing partner.The collaboration follows Ainos' successful implementations in Japan's eldercare sector and semiconductor smart factories. The technology digitizes scent into Smell ID, enabling machines to interpret and act on scent signals. The digital scent technology market is projected to grow from $1.09B (2023) to $2.56B by 2032, while the electronic nose market is expected to reach $132.6B by 2034.

#AIMD #AIMDW Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia

www.stocktitan.net/news/AIMD/ainos-and-kenm...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25 Water Tower Research has published a report highlighting Ainos' (NASDAQ:AIMD) significant progress in AI-powered scent digitization and healthcare solutions. The company's AI Nose technology achieved 85% accuracy in hygiene monitoring and generated first-time revenues in Q1 2025 from elderly care programs in Japan. Ainos completed integration with ugo's service robots and plans field testing in public infrastructure settings during 2H25. The company expanded its semiconductor partnership with ASE, identifying over 30 use cases for AI Nose. In healthcare, Ainos secured Taiwan regulatory approval for Veldona® human trials targeting HIV-related warts and Sjogren's syndrome, with studies expected to complete by 2H26 and 1H27. Additionally, preliminary results from veterinary studies showed 10-44% symptom improvements in Feline Chronic Gingivostomatitis with reduced steroid usage.

#AIMD #AIMDW Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

www.stocktitan.net/news/AIMD/water-tower-re...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Ainos Transforms Smell into Digital Data: 412% Revenue Surge as AI Nose Tech Deploys in Japan AI-powered smell technology drives record growth at Ainos. New partnerships with robotics and semiconductor giants expand commercial reach. See deployment metrics.

#AIMD #AIMDW Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy

www.stocktitan.net/news/AIMD/ainos-issues-m...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Revolutionary AI Nose Gives Robots Sense of Smell: $76B Market Opportunity Unveiled at COMPUTEX First-ever real-time robotic smell detection achieves 90% accuracy in healthcare. Partnership with Japan's top robotics firm opens $76.5B market. See live demo details.

#AIMD #AIMDW Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner

www.stocktitan.net/news/AIMD/ainos-showcase...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy Early results show steroid-free remission, opening pathway into $13B global pet dental health marketVELDONA delivers consistent anti-inflammatory effects, strengthening Ainos' positioning in companion animal immunotherapySAN DIEGO, CALIFORNIA / ACCESS Newswire / May 19, 2025 / Ainos, Inc.

#AIMD #AIMDW Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy

www.stocktitan.net/news/AIMD/ainos-reports-...

0 0 0 0

StockTitan

@stocktitan.net

10 months ago

Ainos Reports Massive 412% Revenue Surge: AI-Powered Scent Technology Breakthrough Targets $50B Market AI Nose achieves 80% accuracy in elderly care, expands to robotics and semiconductor markets. See how Ainos is revolutionizing scent detection technology. Get insights.

#AIMD #AIMDW Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors

www.stocktitan.net/news/AIMD/water-tower-re...

1 0 0 0

StockTitan

@stocktitan.net

10 months ago

Ainos Reports First Quarter 2025 Financial Results Ainos (NASDAQ:AIMD) reported strong Q1 2025 financial results, with revenue surging 412% year-over-year to $106,207, primarily driven by AI Nose product sales. The company achieved a significant turnaround from a gross loss to a gross profit of $87,974. Ainos's AI Nose technology, initially focused on healthcare, is expanding into robotics and industrial sectors through strategic partnerships with ugo Inc. (Japanese robotics leader) and Advanced Semiconductor Engineering (semiconductor packaging giant). The company also advanced its VELDONA® therapeutic program, securing TFDA approval for HIV oral warts trials and IRB clearance for Sjögren's syndrome trials in Taiwan. The electronic nose market is projected to grow from $29.8 billion in 2025 to $76.5 billion by 2032, positioning Ainos to capitalize on the expanding AI and robotics sectors.

#AIMD #AIMDW Ainos Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/AIMD/ainos-reports-...

0 0 0 0

StockTitan

@stocktitan.net

10 months ago

Revolutionary AI Smell Detection System Enters Semiconductor Manufacturing Through ASE Partnership Ainos brings AI-powered scent digitization to semiconductor manufacturing, enabling real-time VOC monitoring and predictive analytics. Learn implementation details.

#AIMD #AIMDW Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

www.stocktitan.net/news/AIMD/ainos-forms-pa...

0 0 0 0

StockTitan

@stocktitan.net

11 months ago

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan Ainos (NASDAQ:AIMD) has achieved significant milestones in advancing its VELDONA® oral interferon drug platform. The company secured TFDA approval for HIV-related oral warts clinical trial and IRB clearance for Sjögren's Syndrome study in Taiwan.The HIV oral warts trial (Protocol ID: 03HUHI19) will commence in June 2025 at National Taiwan University Hospital, targeting completion in 2H 2026. The global market for HIV-related HPV manifestations is estimated at $500-700 million.The Sjögren's Syndrome trial (Protocol ID: 24PSS01) received IRB approval from Taipei Medical University, with TFDA clearance expected in August 2025. The trial aims to evaluate VELDONA's efficacy in improving salivary flow and alleviating dryness symptoms, targeting completion in 1H 2027. The global Sjögren's Syndrome therapeutics market is projected to reach $3.3 billion by 2030.

#AIMD #AIMDW Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

www.stocktitan.net/news/AIMD/ainos-secures-...

0 0 0 0

Posts tagged #AIMDW